Stock Analysis on Net

Celgene Corp. (NASDAQ:CELG)

This company has been moved to the archive! The financial data has not been updated since October 31, 2019.

Income Statement
Quarterly Data

Celgene Corp., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015 Dec 31, 2014 Sep 30, 2014 Jun 30, 2014 Mar 31, 2014
Net product sales 4,518 4,399 4,024 4,036 3,890 3,808 3,531 3,479 3,283 3,259 2,952 2,977 2,969 2,745 2,495 2,539 2,313 2,254 2,055 2,055 1,957 1,845 1,708
Cost of goods sold, excluding amortization of acquired intangible assets (167) (151) (140) (169) (157) (126) (135) (119) (118) (111) (113) (114) (108) (111) (106) (105) (110) (101) (104) (103) (98) (99) (86)
Gross profit 4,351 4,248 3,884 3,867 3,733 3,682 3,396 3,360 3,165 3,148 2,839 2,863 2,861 2,634 2,389 2,434 2,203 2,153 1,951 1,952 1,859 1,746 1,621
Other revenue 2 1 1 1 2 6 7 4 4 12 10 4 14 10 17 24 22 24 26 31 25 28 23
Research and development (1,167) (1,100) (1,216) (1,138) (1,081) (1,251) (2,203) (2,738) (1,347) (835) (995) (1,135) (1,654) (949) (733) (777) (1,305) (1,110) (506) (585) (675) (457) (714)
Selling, general and administrative (781) (793) (773) (850) (746) (790) (864) (774) (608) (939) (620) (685) (698) (732) (543) (609) (550) (617) (529) (544) (498) (492) (494)
Amortization of acquired intangible assets (109) (109) (109) (127) (127) (127) (87) (79) (80) (88) (82) (105) (87) (175) (92) (88) (64) (64) (64) (64) (64) (65) (66)
Acquisition/integration related income (charges) and restructuring, net (32) (136) (77) 54 (101) (34) (31) 1,425 (49) 13 (39) (13) (25) 36 (36) (84) (226) 29 (19) (38) (2) (1) (9)
Operating income 2,264 2,111 1,710 1,807 1,680 1,486 218 1,198 1,085 1,311 1,113 930 412 824 1,002 900 80 416 859 752 647 759 362
Interest and investment income, net 45 38 34 15 8 9 13 33 33 24 15 9 7 7 7 5 9 9 9 8 7 7 6
Interest expense (190) (192) (192) (190) (193) (192) (166) (142) (127) (126) (127) (127) (128) (123) (122) (125) (89) (48) (49) (52) (54) (42) (29)
Other income (expense), net (202) (136) 262 (515) (117) 4 965 42 (31) 13 (313) (34) (13) 35 (35) (20) 95 8 3 (23) (18) (7)
Other income and (expense) (347) (290) 104 (690) (302) (179) 812 (67) (94) (133) (99) (431) (155) (129) (80) (155) (100) 55 (32) (41) (69) (52) (30)
Income (loss) before income taxes 1,917 1,821 1,814 1,117 1,378 1,307 1,030 1,131 991 1,178 1,014 499 257 695 922 746 (20) 471 827 711 578 707 332
Income tax provision (226) (250) (269) (44) (296) (262) (184) (1,212) (3) (77) (82) (70) (85) (97) (121) (185) (14) (115) (108) (97) (69) (109) (53)
Net income (loss) 1,691 1,571 1,545 1,073 1,082 1,045 846 (81) 988 1,101 932 429 171 598 801 561 (34) 356 719 614 509 598 280

Based on: 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31), 10-K (reporting date: 2018-12-31), 10-Q (reporting date: 2018-09-30), 10-Q (reporting date: 2018-06-30), 10-Q (reporting date: 2018-03-31), 10-K (reporting date: 2017-12-31), 10-Q (reporting date: 2017-09-30), 10-Q (reporting date: 2017-06-30), 10-Q (reporting date: 2017-03-31), 10-K (reporting date: 2016-12-31), 10-Q (reporting date: 2016-09-30), 10-Q (reporting date: 2016-06-30), 10-Q (reporting date: 2016-03-31), 10-K (reporting date: 2015-12-31), 10-Q (reporting date: 2015-09-30), 10-Q (reporting date: 2015-06-30), 10-Q (reporting date: 2015-03-31), 10-K (reporting date: 2014-12-31), 10-Q (reporting date: 2014-09-30), 10-Q (reporting date: 2014-06-30), 10-Q (reporting date: 2014-03-31).

Income statement item Description The company
Net product sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Celgene Corp. net product sales increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Operating income The net result for the period of deducting operating expenses from operating revenues. Celgene Corp. operating income increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Income (loss) before income taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Celgene Corp. income (loss) before income taxes increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.
Net income (loss) The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Celgene Corp. net income (loss) increased from Q1 2019 to Q2 2019 and from Q2 2019 to Q3 2019.